← SynDRA
BI.D1870
SynDRA canonical compound SYN1970360 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | RPS6KA1 | RPS6KA2 | RPS6KA3 | RPS6KA6 |
| Mechanism of action | ribosomal protein inhibitor |
All known targets
- RPS6KA1
- RPS6KA2
- RPS6KA3
- RPS6KA6
Mechanisms of action (all sources)
- ribosomal protein inhibitor
Cross-references
Synonyms
- BI-D1870
- 2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one
- 2-(3,5-difluoro-4-hydroxyanilino)-5,7-dimethyl-8-(3-methylbutyl)-7H-pteridin-6-one
- 2-[(3,5-DIFLUORO-4-HYDROXYPHENYL)AMINO]-7,8-DIHYDRO-5,7-DIMETHYL-8-(3-METHYLBUTYL)-6(5H)-PTERIDINONE
- 2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one.
- BI-D-1870
- CHEMBL573107
- GTPL8038
- SCHEMBL13881333
- BDBM25017
- BID1870
- DTXSID40648506
- BCPP000343
- HMS3244C11
- HMS3244C12
- HMS3244D11
- HMS3651D17
- HMS3674C15
- BCP01977
- EX-A2471
- MFCD11223662
- NSC747342
- s2843
- AKOS015918879
- BCP9000401
- CCG-268540
- CS-1243
- NSC-747342
- SB19282
- 2-(3,5-difluoro-4-hydroxyphenylamino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one
- AC-32826
- AS-16192
- HY-10510
- DB-071116
- FT-0720677
- SW219252-1
- 437D281
- BI-D1870 is known as an inhibitor of RSK1-4.
- J-505744
Look up BI.D1870 in the interactive SynDRA portal →